Enhance Your Cell and Gene Therapy Workflow with GenScript Tools

Cell therapy offers a new treatment option for a wide variety of diseases. Most cell therapies involve injecting a specific cell type into the patient. Before transplation, cell needs to be purified to remove the unwanted cell types and the most commonly used cell types are T cells and NK cells. Therefore, cell isolation is performed in laboratory settings for cell therapy and drug discovery research as well as in core facilities for cell manufacturing and cell banking workflow. Furthermore, manufacturing high-quality, consistent and effective cell therapy products requires high-quality reagents from established manufacturing partners with supply chain security.

 

In this webinar, the reagents, consumables and platform developed by GenScript will be shared for cell therapy workflow. The immunomagnetic technology for T cell and NK cell isolation will also be introduced by Dr. Yu. You will be able to learn how researchers scale up their operations and integrate with other instruments for all necessary cell processing steps easily.

 

CRISPR and associated Cas9 enzymes make gene editing both in vitro and in vivo more efficient, more accurate, and less time-consuming than other gene editing methods. Gene editing efficiency by RNP-mediated methods can be improved by appropriate optimization generally. In this webinar, the development, mechanism, and applications of CRISPR gene editing will be briefly introduced by Dr. Shen. The optimization strategy of improving editing efficiency and experimental data will also be shared. In the end, you will hear how CRISPR gene editing solutions and GMP Grade Cas9 protein products from GenScript can facilitate your project.

 

Learning Objectives